Annora Pharma Private Limited, a active private limited company, was established on 26 November 2015 in Village, Gummadidala Mandal, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100TG2015PTC101939. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹316.00 Cr and a paid-up capital of ₹286.00 Cr.
It upholds a compliant status. Its leadership includes Govindaraju Bhavani (Director), Mahesh Ramappa Kamalamma Hassan (Director), Bhaskarreddy Pabbatireddy (Director). Past directors included Govindaraju Bhavani, Chittajallu Gopalakrishna, Mahesh Ramappa Kamalamma Hassan. It holds ₹610.82 Cr open charges and no settled loans. Its latest AGM occurred on 05 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sy.No.261, Plot No.5,7,8,9,13 And 14, Village, Gummadidala Mandal, Telangana, 502313.
U24100TG2015PTC101939
101939
26 November 2015
₹316.00 Cr
₹286.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Annora Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Govindaraju Bhavani | Director | 30 Jun 2022 | Current |
| Mahesh Ramappa Kamalamma Hassan | Director | 30 Mar 2018 | Current |
| Bhaskarreddy Pabbatireddy | Director | 05 Mar 2020 | Current |
| Palleswara Rao Palapatla Govada | Director | 26 Nov 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 22 Sep 2022 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 30 Aug 2018 | Past |
| Pramod Abcsdd | Additional Director | 03 Sep 2020 | Past |
| Pramod Abcsdd | Cfo | - | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Annora Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.62% increase. The company also saw a substantial improvement in profitability, with a 221.74% increase in profit. The company's net worth Soared by an impressive increase of 31.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Annora Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹6,108,171,289.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2024 | Others | ₹214.50 Cr | Open |
| 20 Dec 2023 | Axis Bank Limited | ₹160.00 Cr | Open |
| 22 Mar 2023 | Others | ₹0.90 M | Open |
| 10 Sep 2022 | Others | ₹0.90 M | Open |
| 30 Apr 2022 | Others | ₹3.80 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Annora Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Annora Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Annora Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Annora Pharma Private Limited last Annual general meeting of members was held on 05 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Annora Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
The activity Kiran Kumar Manikwar was appointed as a Company Secretary was appointed as a Company Secretary on 21 Mar 2025 & has been associated with this company since 8 months 11 days . was completed.
Progress on A charge with Others amounted to Rs. 214.50 Cr with Charge ID 101022522 was registered on 30 Dec 2024. was documented.
The activity Bandi Venkatarami Reddy was appointed as a Cfo was appointed as a Cfo on 13 Dec 2024 & has been associated with this company since 11 months 18 days . was completed.
Progress on A charge with Axis Bank Limited amounted to Rs. 160.00 Cr with Charge ID 100844888 was registered on 20 Dec 2023. was documented.
The CIN of Annora Pharma Private Limited is U24100TG2015PTC101939.
Annora Pharma Private Limited is headquartered at Sy.No.261, Plot No.5,7,8,9,13 And 14, Village, Gummadidala Mandal, Telangana, 502313.
Annora Pharma Private Limited was incorporated on 26 November 2015.
The current directors of Annora Pharma Private Limited are
The primary industry of Annora Pharma Private Limited is Manufacturing.
Annora Pharma Private Limited is unlisted.
The authorized capital of Annora Pharma Private Limited is ₹316.00 Cr, and the paid-up capital is ₹286.00 Cr.
The compliance status of Annora Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX